Investors & News

Investor Relations

Stock price graph
     

MAP Pharmaceuticals is an innovative drug company focused on providing better treatments for patients with neurological diseases. Taking an integrated scientific approach, MAP Pharmaceuticals seeks to place better care into patients' hands by enhancing how proven drugs perform, through targeted dosing regimens and novel delivery systems. MAP Pharmaceuticals' goal is to develop treatments that provide patients with greater control, improved efficacy and fewer side effects.

Recent Releases

Feb 8, 2012
MAP Pharmaceuticals to Present at Upcoming Investor Conferences

Jan 17, 2012
MAP Pharmaceuticals Appoints W. James O'Shea to Board of Directors

Jan 4, 2012
MAP Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference

View all »   RSS

Events & Presentations

Feb 28, 2012 at 8:00 AM ET
2012 Citi Global Healthcare Conference

View all »

 

 

Stock Quote
(NASDAQ:MAPP)

Price:
15.82
Change:
- 0.31
Day High:
16.17
Day Low:
15.78
Volume:
83,300
3:28 PM ET on Feb 22, 2012
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools